Annotated Medicine and Device Lists


Mefloquine

This medicine is present in:

List Section Observation
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.03. FARMACOS ANTIPARASITARIOS No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Infectives Antimalarials No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 8 TABLETAS.
Paraguay. Lista de Medicamentos Esenciales. 2009 01. ANTIPROTOZOARIOS No observations
Guyana. Essential Medicines List. 2020-2021 Reserve second-line medicines used to treat Malaria No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 8:20 Antimalarial agents No observations
Haiti. National List of Essential Medicines 06.05.03.02 For prophylaxis Others observations:
For use in pregnancy instead of doxycycline
Barbados. Barbados National Drug Formulary (BNDF) 08.30 Antiprotozoals No observations
Bahamas. Drug Formulary 07.04.01 Antimalarials No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 05.04.01 Antimalarial Drugs No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.5.3.2 For chemoprevention Age or weight restriction: >5 kg or >3 months.
Others observations:
>5 kg or >3 months.
WHO Model List of Essential Medicines (2021) 6.5.3.1. For curative treatment Others observations:
To be used in combination with artesunate 50 mg.
PAHO Strategic Fund Medicine List 2.7.2. Anti-malarial No observations
Peru 6.5.3 Antimalarials No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 07.06 ANTI-MALARIALS No observations
Suriname. NGK-C-011 6.10 Anti-Protozoan Agents: Anti-Malaria Agents No observations

Information Resources: Mefloquine

Loading ...
Loading ...
Loading ...
No information available